🇺🇸 COLISTIN SULFATE in United States

267 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Renal Failure Acute — 45 reports (16.85%)
  2. Drug Ineffective — 38 reports (14.23%)
  3. Infection — 34 reports (12.73%)
  4. Pyrexia — 25 reports (9.36%)
  5. Sepsis — 25 reports (9.36%)
  6. Blood Creatinine Increased — 21 reports (7.87%)
  7. Drug Interaction — 21 reports (7.87%)
  8. Condition Aggravated — 20 reports (7.49%)
  9. Cystic Fibrosis — 19 reports (7.12%)
  10. Septic Shock — 19 reports (7.12%)

Source database →

COLISTIN SULFATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is COLISTIN SULFATE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for COLISTIN SULFATE in United States?

Marketing authorisation holder not available in our data.